CK
VIVS

Carnick & Kubik’s VivoSim Labs VIVS Stock Holding History

Carnick & Kubik’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$0 Buy
+1
New +$508 ﹤0.01% 1000
2015
Q4 		– Sell
-1
Closed -$402 – 340
2015
Q3 		$402 Buy
+1
New +$759 ﹤0.01% 405

Other funds holding VIVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Carnick & Kubik's VIVS Position: Q1 2016 in Review

Carnick & Kubik opened a new position in VivoSim Labs (VIVS) in Q1 2016: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1000 among its holdings. This is a return to the name: Carnick & Kubik previously reported a position in VIVS as recently as Q3 2015.

Carnick & Kubik first reported a position in VIVS in Q3 2015 and has held it in 2 quarters since. The position peaked at $402 in Q3 2015. 109 funds tracked by Wall St. Rank hold VIVS as of Q1 2016.

  • Carnick & Kubik held 1 share of VivoSim Labs worth $0 as of Q1 2016.
  • VivoSim Labs was a new Carnick & Kubik position in Q1 2016.
  • VivoSim Labs made up ﹤0.01% of Carnick & Kubik's portfolio in Q1 2016, its #1000 holding.
  • Carnick & Kubik first reported a position in VivoSim Labs in Q3 2015 and has held it in 2 quarters since.
  • Carnick & Kubik's VivoSim Labs position peaked at $402 in Q3 2015.
  • 109 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.